Fuel cells convert the chemical energy of a fuel into electricity through separated electrochemical half-reactions. Because they are not heat engines, their efficiency is set by the ratio between the Gibbs free energy and the enthalpy of the cell reaction (ΔG/ΔH ≈ 83% for H 2 /O 2 at 25 °C, higher-heating-value basis) and is not bounded by the Carnot factor of a thermal cycle; this, rather than any exemption from the second law, is the origin of the efficiency advantage of fuel cells, which is pronounced at small scale and part load. Realizing that, in practice, the advantage is limited by the electrolyte. Perfluorosulfonic acid (PFSA) ionomers such as Nafion® remain the benchmark. They are costly to fluorinate, lose conductivity when dehydrated above ∼80 °C or at low relative humidity, are vulnerable to radical-induced degradation and reactant crossover, and belong to the per- and polyfluoroalkyl substances (PFAS) now under regulatory pressure. These four constraints underpin the biopolymer- and nanomaterial-based alternatives examined. This review synthesizes strategies in membrane engineering, catalyst design, and energy conversion efficiency for proton exchange membrane cells and related architectures. Biopolymer membranes derived from chitosan and tamarind seed polysaccharide, combined with crosslinking and hybridization, reach proton conductivities above 0.2 S cm −1 while reducing fuel crossover and improving stability. Functionalized graphene oxide (sulfonation, phosphorylation, and three-dimensional sponge-like architectures) provides continuous, spatially stable ionic channels and acts as a barrier to methanol and hydrogen; the conductivities reported for self-supported graphene oxide films are, however, in-plane values and are not directly comparable with the through-plane conductivity of commercial membranes. Non-noble-metal catalysts and enzymatic bioelectrocatalytic systems, particularly laccase-based oxygen reduction and glucose-oxidizing biofuel cells, eliminate dependence on platinum but remain three to six orders of magnitude below platinum-based systems in power density. Biocatalyst degradation, industrial scalability, experimental reproducibility, and the levelised-cost trade-off between initial material cost and service life remain unresolved. Artificial-intelligence-assisted materials discovery, protein engineering, low-energy routes to graphene oxide, and the expansion of fuel cells into biomedical and portable-electronics niches are likely to convert materials-level gains into deployable technology.
No takes yet. Share an insight, caveat, or question.
Filho et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: